OBIO CAAP® 2017 Kicks Off Just As Toronto Health Innovation Week Launches

OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches. Now in its fifth year, this year’s cohort of 10 high potential health science companies will work with OBIO and a vast network of expert advisors to address key goals and objectives which will position them for successful financing. OBIO CAAP companies are advancing and accelerating the development and commercialization of therapeutics, diagnostics, medical devices and health IT products and services to benefit Ontario and global human health.

OBIO CAAP is a unique program for health science companies who receive personalized coaching, advisor and investor introductions ultimately driving fundraising success leading to business development and growth.
— Gail Garland, CEO, OBIO

Read the Full Press Release HERE